Sponsored by eBay
cipla | Shop on eBay
Buy and sell on the world's online marketplace. Top brands, low prices, and free shipping on many items.
https://ciplabiosimilars.co.za/
Cipla Biosimilars
Jun 12, 2025 - Cipla has a legacy of value based generics. Cipla is also focusing on biosimilars and educating on the science behind these medicines.
ciplabiosimilars
https://www.branco.in/
Best Household Products Manufacturers - Cipla Industries
Feb 21, 2026 - Trusted Household Products Manufacturers in India, Cipla Industries delivers high-quality, durable, and affordable home products. Contact us today!
household productsbestmanufacturersciplaindustries
https://www.financialexpress.com/market/cipla-to-sun-pharma-nomura-rates-these-6-pharma-stocks-riding-the-glp-1-wave-buy-4207858/
Cipla to Sun Pharma: Nomura rates these 6 pharma stocks, riding the GLP-1 wave, 'Buy' - Market News...
The Indian Pharmaceutical Market (IPM) grew 10.1% year-on-year in March 2026, according to the report. Pricing contributed 5.5% to growth, while new product...
https://manufacturing.economictimes.indiatimes.com/news/life-sciences/cipla-launches-yurpeak-for-treatment-of-obesity-and-type-2-diabetes/125893697
Cipla launches Yurpeak for treatment of obesity and type 2 diabetes, ETManufacturing
The launch follows approvals granted to Lilly by the Drugs Controller General of India.
https://pharma.economictimes.indiatimes.com/tag/antimicrobial+resistance+cipla
Antimicrobial resistance cipla - Latest antimicrobial resistance cipla , Information & Updates -...
ETPharma.com brings latest antimicrobial resistance cipla news, views and updates from all top sources for the Indian Pharma industry.
antimicrobial resistancelatest informationciplaupdates
https://cipla.africa/
Cipla Africa
Jun 17, 2026 - At Cipla, we are not mere manufacturers of medication. What we make are memories. Memories that may not have been there to be remembered.
ciplaafrica
https://health.economictimes.indiatimes.com/news/pharma/pharma-industry/indias-cipla-open-to-partnering-with-eli-lilly-to-market-their-obesity-drugs-ceo-says/110012965
India's Cipla open to partnering with Eli Lilly to market their obesity drugs, CEO says,...
Obesity Drugs: Global demand has outpaced supply for Lilly's Mounjaro and Zepbound as well as Danish rival Novo Nordisk's Wegovy and Ozempic. They belong to a...
https://economictimes.indiatimes.com/markets/expert-view/a-big-opportunity-is-beginning-to-unlock-for-us-in-the-us-cipla/articleshow/75804074.cms
cipla: A big opportunity is beginning to unlock for us in the US: Cipla - The Economic Times
'Inhaler opportunity can add to Ciplas position in lung medicines.'
https://economictimes.indiatimes.com/markets/stocks/news/cipla-gets-usfda-nod-for-pulmonary-arterial-hypertension-drug/articleshow/69109763.cms
cipla: Cipla gets USFDA nod for pulmonary arterial hypertension drug - The Economic Times
Cipla said the US sales of Letairis tablets USP stood at USD 943 million in 2018.
https://careers.cipla.com/
Cipla Limited Careers
cipla limitedcareers
https://health.economictimes.indiatimes.com/news/pharma/roche-pharma-india-expands-partnership-with-cipla-for-key-oncology-medicines/76441722
Roche Pharma India expands partnership with Cipla for key oncology medicines, ETHealthworld
Roche Pharma India has signed a "distribution agreement with Cipla to expand the scope of the partnership to include, marketing and distribution of its...
partnership with
https://cfo.economictimes.indiatimes.com/news/cipla-appoints-ashish-adukia-as-global-cfo/93611222
Cfo Movement: Cipla appoints Ashish Adukia as Global CFO, ETCFO
Cfo Movement: Adukia will relieve Dinesh Jain from the additional responsibility of interim Chief Financial Officer.
cfomovementciplaappointsashish
https://health.economictimes.indiatimes.com/news/pharma/moderna-seeks-regulatory-approval-for-its-covid-19-vaccine-in-india/83948645
Cipla: Moderna seeks regulatory approval for its Covid-19 vaccine in India, ETHealthworld
Cipla: Moderna has also informed that the US Government has agreed to donate a certain number of doses of the Moderna Covid-19 vaccine through COVAX to the...
https://health.economictimes.indiatimes.com/news/pharma/i-t-dept-conducts-survey-action-against-cipla/97494817
I-T dept conducts survey action against Cipla, ETHealthworld
Cipla: The company had last week reported, in a regulatory filing, a seven per cent increase in its consolidated net profit at Rs 808 crore in the third...
i tdeptconductssurveyaction
https://brandequity.economictimes.indiatimes.com/news/research/advertising/cipla-aims-to-educate-people-about-obstructive-airway-diseases-via-its-news-ads/61544996
Cipla aims to educate people about obstructive airway diseases via its news ads, ETBrandEquity
The campaign is conceptualized and executed by GREY Group India
https://www.business-standard.com/amp/markets/capital-market-news/stocks-to-watch-cipla-greaves-cotton-pc-jeweller-shriram-finance-124121200131_1.html
Stocks to watch: Cipla, Greaves Cotton, PC Jeweller, Shriram Finance | Capital Market News -...
Greaves Cotton board approved OFS of certain shares of arm Greaves Electric held by the company in the proposed IPO.
stocks to watch
https://health.economictimes.indiatimes.com/news/diagnostics/cipla-completes-successful-phase-3-clinical-study-of-generic-asthma-drug/74950101
Cipla completes successful phase-3 clinical study of generic asthma drug, ETHealthworld
The Phase-3 study, which successfully completed in the first attempt, was conducted over a period of 15 months at over 100 sites in the US enrolling 1,400...
clinical study
https://health.economictimes.indiatimes.com/news/pharma/cipla-to-acquire-33-stake-in-clean-max-auriga-power/88308435
Cipla to acquire 33% stake in Clean Max Auriga Power, ETHealthworld
Clean Max Auriga Power LLP is a special purpose vehicle engaged in the business of production, supply, and distribution of solar, wind and other renewable...
ciplaacquirestake
https://health.economictimes.indiatimes.com/news/pharma/cipla-kemwell-form-jv-for-developing-commercialising-biosimilars/85644377
Cipla, Kemwell form JV for developing, commercialising biosimilars, ETHealthworld
Pharma firm Cipla and Kemwell Biopharma on Wednesday announced the execution of a joint venture agreement to develop, manufacture and commercialise biosimilars...
ciplakemwellformjvdeveloping
https://health.economictimes.indiatimes.com/news/pharma/sanofi-cipla-partner-to-boost-cns-portfolio-in-india/108801902
Sanofi & Cipla partner to boost CNS portfolio in India, ETHealthworld
In order to increase patient access to these treatments, Cipla plans to leverage its expertise and strong network of distributors, institutions, and market...
in indiasanoficiplapartnerboost
https://pharma.economictimes.indiatimes.com/tag/cipla+obesity+solutions
Cipla obesity solutions - Latest cipla obesity solutions , Information & Updates - Pharma -ETPharma
ETPharma.com brings latest cipla obesity solutions news, views and updates from all top sources for the Indian Pharma industry.
latest informationciplaobesitysolutionsupdates
https://legal.economictimes.indiatimes.com/tag/cipla+limited
Cipla limited - Latest cipla limited , Information & Updates - Legal -ET LegalWorld
ETLegalWorld.com brings latest cipla limited news, views and updates from all top sources for the Indian Legal industry.
cipla limitedlatest informationupdateslegalet
https://cialisviagras.net/
Review of tablets: Viagra vs Cialis. Order Sildenafil, buy Cipla
Review Generic Viagra, Soft, Super Active and Female. Generic Cialis, Soft, Super Active and Female. You can buy Tadalafil or order Sildenafil. Viagra prices
viagra vs cialisreviewtabletsordersildenafil
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/hetero-cipla-to-supply-generic-remdesivir-to-hospitals-this-week/printprimiumarticle/76501950.cms
experimental covid-19 drug: Hetero, Cipla to supply generic Remdesivir to hospitals this week - The...
The recommended course for a Covid-19 patient under oxygen support is five vials. The approved therapy is for moderate to severe patients.
https://manufacturing.economictimes.indiatimes.com/news/life-sciences/cipla-gears-up-to-enter-obesity-drug-market/122427088
Cipla Gears up to Enter Obesity Drug Market, ETManufacturing
Cipla is gearing up to make waves in India's weight management arena as part of its proactive approach to combatting the growing obesity epidemic.
up tociplagearsenterobesity
https://health.economictimes.indiatimes.com/news/pharma/cipla-gets-usfda-nod-for-generic-inhaler/75063534
Cipla gets USFDA nod for generic inhaler, ETHealthworld
"We are pleased to receive the final approval for generic Albuterol MDI from the USFDA. This further strengthens our presence in the US market," Cipla MD and...
ciplagetsusfdanodgeneric
https://health.economictimes.indiatimes.com/news/pharma/cipla-announces-closure-of-usfda-inspection-at-patalganga-facility/73419250
Cipla announces closure of USFDA inspection at Patalganga facility, ETHealthworld
Cipla: "Following the inspection by the United States Food and Drug Administration (USFDA) at the Patalganga manufacturing facility of the company from...
ciplaannouncesclosureusfdainspection
https://www.business-standard.com/markets/news/cipla-zooms-5-on-2-53-stake-sale-by-hamied-family-okasa-pharma-124051500251_1.html
Cipla zooms 5% on 2.53% stake sale by Hamied family, Okasa Pharma | News on Markets - Business...
Promoters Shirin Hamied, Rumana Hamied, Samina Hamied and Okasa Pharma Private Limited have sold 2.53 per cent shares of Cipla for an undisclosed amount
https://health.economictimes.indiatimes.com/news/pharma/cipla-to-invest-rs-26-crore-in-goapptiv-to-raise-stake-to-22-pc/92500464
Cipla to invest Rs 26 crore in GoApptiv to raise stake to 22 pc, ETHealthworld
Goapptiv: The investment will be made in equity shares and Compulsorily Convertible Preference Shares and is likely to be completed within 30 days or such...
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/cipla-issues-voluntary-nationwide-recall-six-batches-albuterol-sulfate-inhalation-aerosol-90-mcg-200
Cipla Issues Voluntary Nationwide Recall of Six Batches of Albuterol Sulfate Inhalation Aerosol, 90...
Cipla Limited (BSE: 500087; NSE: CIPLA EQ; and hereafter referred to as "Cipla"), today announced that its wholly-owned subsidiary Cipla US is voluntarily...
https://pharma.economictimes.indiatimes.com/news/drug-approvals-and-launches/emcure-enters-weight-loss-market-with-poviztra-undercuts-ciplas-yurpeak-on-price/126118927
Emcure Launches Poviztra, Affordable Weight-Loss Drug Competing with Cipla's Yurpeak, ETPharma
Weight-loss Drug: Emcure Pharmaceuticals enters the Indian weight-loss market with Poviztra, a new drug undercutting Cipla's Yurpeak on price. The drug, based...
weight loss drug
https://pharma.economictimes.indiatimes.com/news/pharma-industry/pfizer-cipla-ink-exclusive-marketing-distribution-pact-for-4-brands/126076328
Pfizer and Cipla Join Forces: Exclusive Marketing Agreement for Key Medicines in India, ETPharma
Pfizer and Cipla have announced an exclusive partnership to market and distribute four key brands in India, enhancing access to vital medications for patients...
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/usfda-pulls-up-cipla-for-manufacturing-lapses-at-pithampur-plant/articleshow/105422470.cms
usfda: USFDA pulls up Cipla for manufacturing lapses at Pithampur plant - The Economic Times
A warning letter is issued when the US health regulator finds that a manufacturer has significantly violated its regulations. "Your firm failed to thoroughly...
https://health.economictimes.indiatimes.com/news/pharma/cipla-dndi-launch-4-in-1-antiretroviral-treatment-for-children-with-hiv/92216747
Cipla, DNDi launch 4-in-1 antiretroviral treatment for children with HIV, ETHealthworld
South African Health Products Regulatory Authority (SAHPRA) has approved the sweet-tasting, heat-stable and '4-in-1' fixed-dose combination of four...
treatment for children
https://www.prnewswire.com/in/news-releases/cipla-health-reinforces-importance-of-self-care-this-season-through-its-range-of-wellness-products-302495467.html
Cipla Health reinforces importance of Self-Care This Season Through Its Range of Wellness Products
/PRNewswire/ -- Common flu, seasonal throat infections, and fevers are on the rise in India, making it imperative to practice every day self-care and...
https://health.economictimes.indiatimes.com/tag/cipla
Cipla - Latest cipla , Information & Updates - Health -ET HealthWorld
ETHealthworld.com brings latest cipla news, views and updates from all top sources for the Indian Health industry.
latest informationciplaupdateshealthet
https://economictimes.indiatimes.com/markets/stocks/news/cipla-shares-in-focus-after-deal-to-acquire-inzpera-healthsciences-for-rs-111-crore/articleshow/125075539.cms?code=unknown&aff_unique2=unknown
Cipla shares in focus after deal to acquire Inzpera Healthsciences for Rs 111 crore - The Economic...
Cipla shares: Cipla has agreed to acquire a 100% stake in Inzpera Healthsciences, making it a wholly owned subsidiary, as part of its strategy to strengthen...
https://www.business-standard.com/companies/news/cipla-to-acquire-ivia-beaute-s-cosmetics-personal-care-biz-for-rs-130-cr-124041600197_1.html
Cipla to acquire Ivia Beaute's cosmetics, personal care biz for Rs 130 cr | Company News - Business...
Apr 16, 2024 - Pharma major Cipla Ltd will acquire the cosmetics and personal care distribution and marketing business of Ivia Beaute Pvt Ltd, including the latter's brands...
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/hetero-cipla-to-supply-generic-remdesivir-to-hospitals-this-week/articleshow/76501950.cms?from=mdr
experimental covid-19 drug: Hetero, Cipla to supply generic Remdesivir to hospitals this week - The...
The recommended course for a Covid-19 patient under oxygen support is five vials. The approved therapy is for moderate to severe patients.
https://www.business-standard.com/amp/markets/capital-market-news/cipla-allots-23-282-equity-shares-under-esos-125041700799_1.html
Cipla allots 23,282 equity shares under ESOS | Capital Market News - Business Standard
Consequently, the issued, subscribed and paid-up share capital of the Company stands increased to Rs 1,61,52,80,804 comprising of 80,76,40,402 equity shares of...
https://www.business-standard.com/amp/content/press-releases-ani/cipla-health-reinforces-importance-of-self-care-this-season-through-its-range-of-wellness-products-125070100849_1.html
Cipla Health reinforces importance of Self-Care This Season Through Its Range of Wellness Products
Mumbai (Maharashtra) [India], July 1: Common flu, seasonal throat infections, and fevers are on the rise in India, making it imperative to practice every day...
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/cipla-to-market-msds-hiv-drug-raltegravir-in-india/articleshow/30723869.cms?from=mdr
Cipla to market MSD's HIV drug 'raltegravir' in India - The Economic Times
MSD in India Managing Director K G Ananthakrishnan said the partnership is aligned with the company's commitment towards patients in India.
https://manufacturing.economictimes.indiatimes.com/news/life-sciences/cipla-launches-afrezza-a-revolutionary-inhalable-insulin-for-diabetes-management/126123340
Cipla Launches Afrezza: A Revolutionary Inhalable Insulin for Diabetes Management, ETManufacturing
Cipla has introduced Afrezza, an inhalable insulin powder, providing a convenient, needle-free option for diabetes care in India. This innovation aims to...
for diabetesciplalaunchesafrezzarevolutionary
https://health.economictimes.indiatimes.com/news/pharma/cipla-health-ventures-into-antifungal-product-category-with-clocip/77995317
Cipla Health ventures into Antifungal Product Category with Clocip, ETHealthworld
Available in two forms, the Clocip Clotrimazole Absorbent Dusting Powder and Clocip Clotrimazole Cream have specially formulated antibacterial and antifungal...
product categoryciplahealthventuresantifungal
https://health.economictimes.indiatimes.com/news/pharma/usfda-designates-ciplas-goa-plant-as-official-action-indicated/95738205
USFDA designates Cipla's Goa plant as 'Official Action Indicated', ETHealthworld
Cipla states that an FDA inspection revealed significant objectionable conditions or practices and action must be taken to address the issues.
usfdaciplagoa
https://www.business-standard.com/amp/markets/capital-market-news/cipla-jumps-on-receiving-approval-from-usfda-for-protein-bound-paclitaxel-125041100280_1.html
Cipla jumps on receiving approval from USFDA for protein-bound Paclitaxel | Capital Market News -...
Cipla rallied 3.80% to Rs 1,470.15 after the firm received final approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug...
https://adisinsight.springer.com/patents/800028439
Azelastine/fluticasone propionate - Cipla/Meda - AdisInsight
fluticasone propionateazelastineciplamedaadisinsight
https://www.business-standard.com/amp/markets/news/cipla-q1-preview-restructure-in-biz-may-dent-sales-profits-to-rise-7-124072400281_1.html
Cipla Q1 Preview: Restructure in biz may dent sales; profits to rise 7% | News on Markets -...
Cipla is expected to see a decent June quarter with revenues estimated to increase in upper single digits on a year on year basis and net profits seeing a mid...
https://health.economictimes.indiatimes.com/news/pharma/cipla-to-buy-32-49-per-cent-stake-in-solar-power-firm/89357552
Cipla to buy 32.49 per cent stake in solar power firm, ETHealthworld
The acquisition is in line with the commitment to enhance the share of renewable power sources in its operation and to comply with regulatory requirements for...
https://www.business-standard.com/amp/companies/news/cipla-health-signs-agreement-strengthens-beauty-play-with-ivia-s-brands-124041501029_1.html
Cipla Health signs agreement, strengthens beauty play with Ivia's brands | Company News - Business...
Cipla Health strengthens beauty play in Tier II-VI towns with Ivia Beaute's cosmetics, personal care distribution and marketing biz
https://hr.economictimes.indiatimes.com/news/industry/cipla-appoints-arun-kakatkar-as-global-chief-people-officer/127856781
Cipla Names Arun Kakatkar as New Global Chief People Officer, ETHRWorld
Cipla has appointed Arun Kakatkar as its Global Chief People Officer, bringing years of leadership experience from Microsoft and various industries. He will...
chief people officeras newciplanamesarun
https://health.economictimes.indiatimes.com/news/pharma/cipla-boehringer-ingelheim-join-hands-to-co-market-3-oral-anti-diabetic-drugs-in-india/76691137
Cipla, Boehringer Ingelheim join hands to co-market 3 oral anti-diabetic drugs in India,...
As per the International Diabetes Federation, India is home to 7.7 crore diabetic adults aged between 20-79 years, ranking second behind China, and is poised...
https://health.economictimes.indiatimes.com/news/pharma/pharma-industry/sanofi-india-cipla-limited-partner-to-distribute-promote-cns-products-range-in-india/108815278
Rodolfo Hrosz: Sanofi India, Cipla Limited partner to distribute, promote CNS products range in...
Rodolfo Hrosz: While Sanofi India will continue to own, import, and manufacture its complete range of CNS products across plants in India and internationally,...
https://manufacturing.economictimes.indiatimes.com/news/life-sciences/sun-pharma-cipla-recall-products-in-us-market-usfda/127540171
Sun Pharma, Cipla recall products in US market: USFDA, ETManufacturing
Sun Pharma and Cipla are recalling products in the US due to manufacturing issues. Sun Pharma is recalling generic dandruff medication and Clindamycin...
sun pharmain usciplarecallproducts
https://health.economictimes.indiatimes.com/news/medical-devices/cipla-launches-spirofy/87750415
Copd: Cipla launches Spirofy, ETHealthworld
Currently, COPD remains the 2nd most common cause of death in India after heart diseases, where India alone bears 32% of the global COPD burden.
copdciplalaunches
https://health.economictimes.indiatimes.com/news/pharma/financial-performance/indian-drugmaker-cipla-beats-q1-profit-view-on-strong-demand-shares-hit-record-high/112046510
Indian drugmaker Cipla beats Q1 profit view on strong demand; shares hit record high, ETHealthworld
"Cipla's rising market share for Lanreotide and Albuterol have led the U.S. revenue to beat our estimates," said Shrikant Akolkar, an analyst at Nuvama...
https://economictimes.indiatimes.com/markets/stocks/earnings/q4-results-today-tata-motors-cipla-among-87-companies-to-announce-earnings/articleshow/109996239.cms
Q4 results today: Tata Motors, Cipla among 87 companies to announce earnings - The Economic Times
Q4 results today: Several other companies scheduled to release their financial results include Cholamandalam Finance, Eicher Motors, Finolex Industries,...
https://health.economictimes.indiatimes.com/news/industry/un-general-assembly-recognizes-cipla-as-leading-partner-to-combat-ncds/87020878
Non Communicable Diseases: UN General Assembly recognizes Cipla as leading partner to combat NCDs,...
Non Communicable Diseases: Counselling, integrating tobacco cessation at primary healthcare, intersectoral linkages, sensitising youth, training of trainers...
non communicable diseases
https://moyomall.co/
에프페시아 l 핀페시아 직구 l 세마볼릭 l 리벨서스ㅣ탈모샴푸 l CIPLA
Jun 9, 2026 - 에프페시아 l 핀페시아 l 두타놀 l 아보스테리드ㅣ세마볼릭, 리벨서스, 직구사이트,성기능, 다이어트, 탈모약,센포스,타스틸리아, 비달리스타,탈모샴푸,국내유일 당일출고 , 힐페시아,CIPLA,Finpecia,직구몰
l
https://pharma.economictimes.indiatimes.com/news/financial-performance/indias-cipla-beats-q2-profit-view-on-strong-us-india-demand/114729654
India's Cipla beats Q2 profit view on strong US, India demand, ETPharma
The company reported a consolidated net profit of 13.03 billion rupees ($155 million) for the quarter ended Sept. 30, beating analysts' estimate of 12.34...
https://health.economictimes.indiatimes.com/news/pharma/cipla-gets-usfda-nod-for-inhalation-product/83771677
Inhalation Solution: Cipla gets USFDA nod for inhalation product, ETHealthworld
Inhalation Solution: The approved product is a generic version of Sunovion Pharmaceuticals Inc's Brovana.
inhalation solutionfor productciplagetsusfda